Ozempic became a headline again with the TGA placing a warning label on GLP-1 RAs for the potential risk of NAION, an eye condition that can cause permanent vision loss. Thank you to @news.abc.net.au for asking me to comment on this issue again. What you need to know: www.abc.net.au/news/2026-07...
Rare eye disorder linked to Ozempic-like medications
The Therapeutic Goods Administration has issued a safety warning for a rare, but serious risk of vision impairment from taking GLP-1-based drugs such as Ozempic and Wegovy.
abc.net.au